Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy

Clinical trial NCT05789394 · RECRUITING

Trial details

NCT number: NCT05789394
Sponsor: Mayo Clinic
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Glioblastoma, IDH-Wildtype Recurrent Astrocytoma, IDH-Mutant, Grade 4 Astrocytoma, Grade IV

Start date: 2023-06-16
Primary completion: 2027-07-24
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.